logo

For the Inventor, By the Inventor

Baltimore, MD, United States of America

Alba Therapeutics Corporation


USPTO Granted Patents = 16

% Expired Patents = 31.3


Forward Citations = 126

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Blake Paterson (9 out of 14 patents)

silverMedal Amir P Tamiz (8 out of 12 patents)

bronzeMedal Sefik Alkan (3 out of 3 patents)

4.  Kelly Marie Kitchens (3 out of 3 patents)

5.  Malarvizhi Durai (3 out of 3 patents)

6.  Neil Poloso (3 out of 3 patents)

7.  Rosa A Carrasco (3 out of 3 patents)

8.  Alessio Fasano (3 out of 30 patents)

9.  Mark J Ginski (3 out of 3 patents)

10.  Niranjan B Pandey (2 out of 14 patents)

11.  Thierry Delplanche (1 out of 9 patents)

12.  Peter Ward (1 out of 1 patent)

13.  Roland Callens (1 out of 25 patents)

14.  Georges Blondeel (1 out of 8 patents)

15.  Dorothea Sesardic (1 out of 1 patent)


16 patents:

1. 11149063 - Peptide inhibitors of tight junction permeability (2021-10-19),
2. 10723763 - Use of tight junction antagonists in the treatment of acute lung injury and acute respiratory distress syndrome (2020-07-28),
3. 10526372 - Inhibition of gliadin peptides (2020-01-07),
4. 9279807 - Materials and methods for the treatment of celiac disease (2016-03-08),
5. 9265811 - Formulations for a tight junction effector (2016-02-23),
6. 9241969 - Method for treating celiac disease (2016-01-26),
7. 9051349 - Larazotide acetate compositions (2015-06-09),
8. 8957032 - Inhibition of gliadin peptides (2015-02-17),
9. 8796203 - Use of tight junction antagonists to treat inflammatory bowel disease (2014-08-05),
10. 8785374 - Inhibitors of mammalian tight junction opening (2014-07-22),
11. 8728491 - Transcutaneous delivery of therapeutic agents (2014-05-20),
12. 8557763 - Synthetic peptides that enhance tight junction permeability (2013-10-15),
13. 8299017 - Use of tight junction antagonists to treat inflammatory bowl disease (2012-10-30),
14. 8198233 - Synthetic peptides that enhance tight junction permeability (2012-06-12),
15. 8168594 - Method for treating celiac disease (2012-05-01),
Company Overview
Alba Therapeutics Corporation, based in Baltimore, MD, is focused on developing innovative therapies for autoimmune and inflammatory diseases. The company specializes in the research and development of novel treatments aimed at addressing unmet medical needs, particularly in the realm of gastrointestinal disorders. With a commitment to advancing therapeutic options, Alba Therapeutics leverages cutting-edge science to create solutions that improve patient outcomes and enhance quality of life.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

16 Patents

#32 in Baltimore, MD

#276 in Maryland

#19,907 in US

#37,788 in the World

Baltimore, MD (US)
Baltimore, MD, United States of America

Alba Therapeutics Corporation

Forward Citations = 126

17 inventors:

goldMedal Blake Paterson (9 out of 14 patents)

silverMedal Amir P Tamiz (8 out of 12 patents)

bronzeMedal Sefik Alkan (3 out of 3 patents)

4.  Kelly Marie Kitchens (3 out of 3 patents)

5.  Malarvizhi Durai (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alba Therapeutics Corporation. Retrieved from https://idiyas.com/company/alba-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…